Here's how one drug can be responsible for 50% of the hike in Medicare's Part B premiums
December 12, 2021 at 09:00 AM EST
About half of the jump in Part B premiums next year is due to the potential cost of covering Aduhelm, a drug targeting Alzheimer's disease. Here's why.
